Literature DB >> 859099

Protein binding of warfarin enantiomers in serum of humans and rats.

A Yacobi, G Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 859099     DOI： 10.1007/BF01066216

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  15 in total

1.  Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors.

Authors:  I Sjöholm; A Kober; I Odar-Cederlöf; O Borgåa
Journal:  Biochem Pharmacol       Date:  1976-05-15       Impact factor: 5.858

2.  Studies on the optical enantiomorphs of warfarin in man.

Authors:  R A O'Reilly
Journal:  Clin Pharmacol Ther       Date:  1974-08       Impact factor: 6.875

3.  The plasma half-lives of the enantiomers of warfarin in warfarin-resistant and warfarin-susceptible rats.

Authors:  D S Hewick
Journal:  J Pharm Pharmacol       Date:  1972-08       Impact factor: 3.765

4.  Pharmacokinetics of the warfarin enantiomers in rats.

Authors:  A Yacobi; G Levy
Journal:  J Pharmacokinet Biopharm       Date:  1974-06

5.  Letter: Effect of plasma protein binding on elimination of warfarin.

Authors:  G Levy; A Yacobi
Journal:  J Pharm Sci       Date:  1974-05       Impact factor: 3.534

6.  Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.

Authors:  A Yacobi; L B Wingard; G Levy
Journal:  J Pharm Sci       Date:  1974-06       Impact factor: 3.534

7.  Interaction of several coumarin compounds with human and canine plasma albumin.

Authors:  R A O'Reilly
Journal:  Mol Pharmacol       Date:  1971-03       Impact factor: 4.436

8.  Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man.

Authors:  D S Hewick; J McEwen
Journal:  J Pharm Pharmacol       Date:  1973-06       Impact factor: 3.765

9.  Effect of plasma protein binding on the anticoagulant action of warfarin in rats.

Authors:  A Yacobi; G Levy
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-10

10.  Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.

Authors:  A Yacobi; J A Udall; G Levy
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875
View more
  17 in total

1.  Species-dependent stereospecific serum protein binding of the oral anticoagulant drug phenprocoumon.

Authors:  W Schmidt; E Jähnchen
Journal:  Experientia       Date:  1978-10-15

Review 2.  Stereoselectivity in clinical pharmacokinetics and drug development.

Authors:  D B Campbell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

3.  Lack of interaction between meloxicam and warfarin in healthy volunteers.

Authors:  D Türck; C A Su; G Heinzel; U Busch; E Bluhmki; J Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

4.  The effect of octanoic acid on the binding of the enantiomers of ibuprofen and naproxen to human serum albumin: a chromatographic implication.

Authors:  V K Cheruvallath; C M Riley; S R Narayanan; S Lindenbaum; J H Perrin
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

5.  Stereoselective binding of propranolol in the elderly.

Authors:  P Colangelo; M Chandler; R Blouin; P McNamara
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

6.  Stereoselective plasma protein binding of ibuprofen enantiomers.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Stereoselective drug disposition: potential for misinterpretation of drug disposition data.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

Review 8.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

9.  Effects of etravirine on the pharmacokinetics and pharmacodynamics of warfarin in rats.

Authors:  J John; M John; L Wu; C Hsiao; C V Abobo; D Liang
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

10.  Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases.

Authors:  Agnieszka Zielinska; Cheryl F Lichti; Stacie Bratton; Neil C Mitchell; Anna Gallus-Zawada; Vi-Huyen Le; Moshe Finel; Grover P Miller; Anna Radominska-Pandya; Jeffery H Moran
Journal:  J Pharmacol Exp Ther       Date:  2007-10-05       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.